Macular-FAG, consisting primarily of a mixture of fatty acids, can ameliorate retinal degenerative events associated with advanced AMD by inhibiting the activation of C3 and C5 in the complement system, thereby reducing macrophage recruitment. Here, C5 is linked to age-related macular degeneration.